Concepts (117)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tay-Sachs Disease | 5 | 2025 | 52 | 1.900 |
Why?
|
| Genetic Therapy | 9 | 2026 | 839 | 1.650 |
Why?
|
| Dependovirus | 8 | 2026 | 751 | 1.590 |
Why?
|
| Sheep | 9 | 2025 | 189 | 1.060 |
Why?
|
| Genetic Vectors | 7 | 2025 | 918 | 1.040 |
Why?
|
| beta-Hexosaminidase alpha Chain | 2 | 2025 | 20 | 0.970 |
Why?
|
| Hexosaminidase A | 1 | 2025 | 6 | 0.920 |
Why?
|
| Huntington Disease | 2 | 2023 | 160 | 0.800 |
Why?
|
| Diabetes Mellitus, Experimental | 3 | 2019 | 206 | 0.750 |
Why?
|
| Cisterna Magna | 2 | 2024 | 17 | 0.660 |
Why?
|
| White Matter | 1 | 2022 | 126 | 0.650 |
Why?
|
| Injections | 1 | 2020 | 84 | 0.630 |
Why?
|
| Thalamus | 1 | 2020 | 77 | 0.600 |
Why?
|
| Gene Transfer Techniques | 2 | 2024 | 325 | 0.560 |
Why?
|
| Cytoplasm | 1 | 2019 | 283 | 0.550 |
Why?
|
| Islets of Langerhans | 1 | 2019 | 286 | 0.540 |
Why?
|
| Transduction, Genetic | 1 | 2019 | 242 | 0.540 |
Why?
|
| NF-kappa B | 1 | 2019 | 435 | 0.530 |
Why?
|
| Gene Expression | 2 | 2020 | 852 | 0.510 |
Why?
|
| Cell Nucleus | 1 | 2019 | 630 | 0.470 |
Why?
|
| Electricity | 1 | 2015 | 9 | 0.460 |
Why?
|
| Electrolytes | 1 | 2015 | 26 | 0.450 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2019 | 630 | 0.420 |
Why?
|
| Disease Models, Animal | 6 | 2025 | 2293 | 0.420 |
Why?
|
| Animals | 17 | 2026 | 21345 | 0.400 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2026 | 2244 | 0.400 |
Why?
|
| Sandhoff Disease | 2 | 2025 | 36 | 0.380 |
Why?
|
| Cell Membrane | 1 | 2015 | 506 | 0.370 |
Why?
|
| Brain | 4 | 2025 | 1605 | 0.330 |
Why?
|
| Models, Biological | 1 | 2015 | 1192 | 0.310 |
Why?
|
| G(M2) Ganglioside | 2 | 2025 | 15 | 0.270 |
Why?
|
| Gangliosidosis, GM1 | 1 | 2026 | 26 | 0.230 |
Why?
|
| beta-Hexosaminidase beta Chain | 1 | 2025 | 8 | 0.230 |
Why?
|
| Gangliosidoses, GM2 | 1 | 2025 | 18 | 0.230 |
Why?
|
| Cerebrospinal Fluid | 1 | 2025 | 29 | 0.220 |
Why?
|
| Tissue Distribution | 2 | 2024 | 293 | 0.220 |
Why?
|
| 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) | 1 | 2025 | 13 | 0.220 |
Why?
|
| Methotrexate | 1 | 2025 | 80 | 0.220 |
Why?
|
| Maple Syrup Urine Disease | 1 | 2025 | 24 | 0.220 |
Why?
|
| Cerebellopontine Angle | 1 | 2024 | 9 | 0.210 |
Why?
|
| Contrast Media | 1 | 2026 | 432 | 0.200 |
Why?
|
| Prodromal Symptoms | 1 | 2023 | 13 | 0.190 |
Why?
|
| Green Fluorescent Proteins | 1 | 2024 | 372 | 0.190 |
Why?
|
| Neurofilament Proteins | 1 | 2023 | 25 | 0.190 |
Why?
|
| Neovascularization, Physiologic | 2 | 2014 | 113 | 0.190 |
Why?
|
| Homeostasis | 1 | 2025 | 379 | 0.180 |
Why?
|
| Transgenes | 2 | 2020 | 204 | 0.180 |
Why?
|
| Central Nervous System | 2 | 2024 | 200 | 0.180 |
Why?
|
| Mutant Proteins | 1 | 2022 | 105 | 0.170 |
Why?
|
| Humans | 9 | 2026 | 65140 | 0.160 |
Why?
|
| Injections, Spinal | 1 | 2019 | 44 | 0.150 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2019 | 56 | 0.150 |
Why?
|
| Catheters | 1 | 2019 | 76 | 0.150 |
Why?
|
| Video Recording | 1 | 2019 | 139 | 0.150 |
Why?
|
| Genes, Reporter | 1 | 2019 | 257 | 0.150 |
Why?
|
| Models, Animal | 1 | 2019 | 241 | 0.140 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2019 | 242 | 0.140 |
Why?
|
| Microscopy, Fluorescence | 1 | 2019 | 401 | 0.140 |
Why?
|
| Fluorescent Dyes | 1 | 2019 | 202 | 0.140 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2020 | 298 | 0.140 |
Why?
|
| Mice | 5 | 2026 | 11119 | 0.130 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 1290 | 0.120 |
Why?
|
| RNA, Small Interfering | 1 | 2021 | 981 | 0.110 |
Why?
|
| Cell Adhesion | 1 | 2015 | 218 | 0.110 |
Why?
|
| Endothelial Cells | 2 | 2014 | 208 | 0.100 |
Why?
|
| Female | 5 | 2025 | 34018 | 0.100 |
Why?
|
| Coronary Vessels | 1 | 2014 | 125 | 0.100 |
Why?
|
| Endothelium, Vascular | 1 | 2014 | 178 | 0.100 |
Why?
|
| Electromagnetic Fields | 1 | 2012 | 15 | 0.090 |
Why?
|
| Capillaries | 1 | 2012 | 34 | 0.090 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 2012 | 2 | 0.090 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2012 | 13 | 0.090 |
Why?
|
| Morphogenesis | 1 | 2012 | 120 | 0.090 |
Why?
|
| Calcium | 2 | 2012 | 584 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 1656 | 0.090 |
Why?
|
| Male | 3 | 2025 | 31047 | 0.080 |
Why?
|
| MAP Kinase Signaling System | 1 | 2012 | 235 | 0.080 |
Why?
|
| Myocardium | 1 | 2012 | 302 | 0.080 |
Why?
|
| Serum Albumin | 1 | 2026 | 47 | 0.060 |
Why?
|
| beta-Galactosidase | 1 | 2026 | 84 | 0.060 |
Why?
|
| Infusions, Intraventricular | 1 | 2025 | 12 | 0.060 |
Why?
|
| Injections, Intraventricular | 1 | 2025 | 23 | 0.060 |
Why?
|
| Aged | 1 | 2022 | 14965 | 0.060 |
Why?
|
| Gadolinium | 1 | 2026 | 110 | 0.060 |
Why?
|
| Blood-Brain Barrier | 1 | 2025 | 87 | 0.050 |
Why?
|
| Cattle | 1 | 2025 | 320 | 0.050 |
Why?
|
| Nitric Oxide | 2 | 2014 | 164 | 0.040 |
Why?
|
| Drug Administration Routes | 1 | 2021 | 22 | 0.040 |
Why?
|
| Huntingtin Protein | 1 | 2023 | 147 | 0.040 |
Why?
|
| Animals, Genetically Modified | 1 | 2023 | 312 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2014 | 234 | 0.040 |
Why?
|
| beta-N-Acetylhexosaminidases | 1 | 2020 | 19 | 0.040 |
Why?
|
| Infant | 1 | 2025 | 1693 | 0.040 |
Why?
|
| Liver | 1 | 2025 | 871 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2025 | 2061 | 0.040 |
Why?
|
| Rats | 2 | 2014 | 1994 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2014 | 1038 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2014 | 2188 | 0.040 |
Why?
|
| Disease Management | 1 | 2020 | 235 | 0.030 |
Why?
|
| Apoptosis | 2 | 2014 | 1098 | 0.030 |
Why?
|
| Endovascular Procedures | 1 | 2024 | 628 | 0.030 |
Why?
|
| Biomarkers | 1 | 2023 | 1480 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 730 | 0.030 |
Why?
|
| Child | 1 | 2025 | 4607 | 0.030 |
Why?
|
| Adolescent | 1 | 2025 | 6297 | 0.030 |
Why?
|
| Culture Media | 1 | 2014 | 78 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2012 | 7 | 0.020 |
Why?
|
| Biomechanical Phenomena | 1 | 2014 | 293 | 0.020 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2012 | 46 | 0.020 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 2012 | 14 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 80 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2012 | 178 | 0.020 |
Why?
|
| Mutation | 1 | 2020 | 2661 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2012 | 624 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2012 | 962 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 1630 | 0.010 |
Why?
|
| Time Factors | 1 | 2012 | 3762 | 0.010 |
Why?
|